New Enterprise Associates's Pharmaceutical Portfolio

Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.

Cardurion is a cardiovascular biotechnology company developing therapeutics for the treatment of heart failure and cardiovascular diseases.

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics

Code Biotherapeutics is a next-generation gene therapy company pioneering the development of targeted non-viral gene therapies.

Tagworks Pharmaceuticals is a privately held biotech company

Reneo Pharmaceuticals is an operator of a pharmaceutical company used to develop therapies for patients with orphan metabolic diseases.

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.

Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.

Spyglass Pharma provides medicine for ophthalmic diseases.

Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.

858 Therapeutics develops small molecule drugs targeting oncology and immunology.

Our purpose is to make every pregnancy around the world safer.

Phathom Pharmaceuticals is a biopharmaceutical company.

Sorriso Pharmaceuticals is a biotech firm developing disease-modifying antibodies for the treatment of inflammatory diseases.

Escient Pharmaceuticals is a privately-held biotechnology company focusing on the advancement of G Protein-Coupled Receptor targeted drugs.

Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.

Resilience is a biomanufacturing company that provides access to complex medicines and protects biopharmaceutical supply chains.

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

Inversago Pharma is a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists

InCarey is a chain pharmacy providing specialty medicines for critical and chronic diseases.

Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product.